CC BY-NC-ND 4.0 · Journal of Digestive Endoscopy 2022; 13(01): 030-035
DOI: 10.1055/s-0041-1740490
Review Article

Achalasia Cardia: Balloon, Tunnel, or Knife?

Amit Maydeo
1   Baldota Institute of Digestive Sciences, Gleneagles Global Hospital, Mumbai, Maharashtra, India
› Author Affiliations
Funding None.

Abstract

Achalasia cardia is a rare esophageal motility disorder characterized by impaired relaxation of the lower esophageal sphincter during swallowing and aperistalsis of the esophageal smooth muscles. The treatment approaches to achalasia include nonsurgical treatment with medications (nitrates, calcium channel blockers), endoscopic treatment (balloon pneumatic dilation [PD], botulinum toxin injection [BTI], peroral endoscopic myotomy [POEM]), and surgery (laparoscopic Heller's myotomy [LHM]). The subtype of achalasia (the Chicago Classification) governs the ideal treatment. For the commonly encountered achalasia subtype I and II, PD, LHM, and POEM all have similar efficacy. However, for type III achalasia, POEM seems to be the best line of treatment. Among high-risk elderly patients or those with comorbidities, BTI is preferred. The choice of treatment should be minimally invasive therapy with good short-term and sustained long-term effects with negligible adverse events. POEM seems to be evolving as a first-line therapy among the available therapies. Here, we review the treatment options among achalasia cardia patients with special attention to post-POEM gastroesophageal reflux disease and its management.



Publication History

Article published online:
20 April 2022

© 2022. Society of Gastrointestinal Endoscopy of India. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Boeckxstaens GE, Zaninotto G, Richter JE. Achalasia. Lancet 2014; 383 (9911): 83-93
  • 2 O'Neill OM, Johnston BT, Coleman HG. Achalasia: a review of clinical diagnosis, epidemiology, treatment and outcomes. World J Gastroenterol 2013; 19 (35) 5806-5812
  • 3 Sadowski DC, Ackah F, Jiang B, Svenson LW. Achalasia: incidence, prevalence and survival. A population-based study. Neurogastroenterol Motil 2010; 22 (09) e256-e261
  • 4 Enestvedt BK, Williams JL, Sonnenberg A. Epidemiology and practice patterns of achalasia in a large multi-centre database. Aliment Pharmacol Ther 2011; 33 (11) 1209-1214
  • 5 Ates F, Vaezi MF. The pathogenesis and management of achalasia: current status and future directions. Gut Liver 2015; 9 (04) 449-463
  • 6 Brücher BL, Stein HJ, Bartels H, Feussner H, Siewert JR. Achalasia and esophageal cancer: incidence, prevalence, and prognosis. World J Surg 2001; 25 (06) 745-749
  • 7 Oude Nijhuis RAB, Zaninotto G, Roman S. et al. European guidelines on achalasia: United European Gastroenterology and European Society of Neurogastroenterology and Motility recommendations. United European Gastroenterol J 2020; 8 (01) 13-33
  • 8 Patel DA, Lappas BM, Vaezi MF. An overview of achalasia and its subtypes. Gastroenterol Hepatol (N Y) 2017; 13 (07) 411-421
  • 9 Rogers BD, Gyawali CP. Evaluation of the esophagogastric junction on high resolution manometry. J Clin Gastroenterol 2021; 55 (02) e8-e18
  • 10 Kahrilas PJ, Bredenoord AJ, Fox M. et al; International High Resolution Manometry Working Group. The Chicago Classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil 2015; 27 (02) 160-174
  • 11 Schlottmann F, Herbella FA, Patti MG. Understanding the Chicago Classification: from tracings to patients. J Neurogastroenterol Motil 2017; 23 (04) 487-494
  • 12 Ghoshal UC, Daschakraborty SB, Singh R. Pathogenesis of achalasia cardia. World J Gastroenterol 2012; 18 (24) 3050-3057
  • 13 Heller E. Extramukose Kardiaplastik beim chronischen Kardiospasmus mit Dilatation des Oesophagus. Mitt Grenzgeb Med Chir 1914; 27: 141-149
  • 14 Payne WS. Heller's contribution to the surgical treatment of achalasia of the esophagus. 1914. Ann Thorac Surg 1989; 48 (06) 876-881
  • 15 Vantrappen G, Vangoidsenhoven GE, Verbeke S, Vandenberghe G, Vanderbroucke J. Manometric studies in achalasia of the cardia, before and after pneumatic dilations. Gastroenterology 1963; 45: 317-325
  • 16 Vantrappen G, Hellemans J, Deloof W, Valembois P, Vandenbroucke J. Treatment of achalasia with pneumatic dilatations. Gut 1971; 12 (04) 268-275
  • 17 Inoue H, Minami H, Kobayashi Y. et al. Peroral endoscopic myotomy (POEM) for esophageal achalasia. Endoscopy 2010; 42 (04) 265-271
  • 18 Raizman RE, De Rezende JM, Neva FA. A clinical trial with pre- and post-treatment manometry comparing pneumatic dilation with bouginage for treatment of Chagas' megaesophagus. Am J Gastroenterol 1980; 74 (05) 405-409
  • 19 Ghoshal UC, Kumar S, Saraswat VA, Aggarwal R, Misra A, Choudhuri G. Long-term follow-up after pneumatic dilation for achalasia cardia: factors associated with treatment failure and recurrence. Am J Gastroenterol 2004; 99 (12) 2304-2310
  • 20 Mehta R, John A, Sadasivan S. et al. Factors determining successful outcome following pneumatic balloon dilation in achalasia cardia. Indian J Gastroenterol 2005; 24 (06) 243-245
  • 21 Zerbib F, Thétiot V, Richy F, Benajah DA, Message L, Lamouliatte H. Repeated pneumatic dilations as long-term maintenance therapy for esophageal achalasia. Am J Gastroenterol 2006; 101 (04) 692-697
  • 22 Bravi I, Nicita MT, Duca P. et al. A pneumatic dilation strategy in achalasia: prospective outcome and effects on oesophageal motor function in the long term. Aliment Pharmacol Ther 2010; 31 (06) 658-665
  • 23 Hirano I, Pandolfino JE, Boeckxstaens GE. Functional lumen imaging probe for the management of esophageal disorders: expert review from the Clinical Practice Updates Committee of the AGA Institute. Clin Gastroenterol Hepatol 2017; 15 (03) 325-334
  • 24 Karamanolis G, Sgouros S, Karatzias G. et al. Long-term outcome of pneumatic dilation in the treatment of achalasia. Am J Gastroenterol 2005; 100 (02) 270-274
  • 25 Mikaeli J, Fazel A, Montazeri G, Yaghoobi M, Malekzadeh R. Randomized controlled trial comparing botulinum toxin injection to pneumatic dilatation for the treatment of achalasia. Aliment Pharmacol Ther 2001; 15 (09) 1389-1396
  • 26 Vaezi MF, Richter JE. Current therapies for achalasia: comparison and efficacy. J Clin Gastroenterol 1998; 27 (01) 21-35
  • 27 Torbey CF, Achkar E, Rice TW, Baker M, Richter JE. Long-term outcome of achalasia treatment: the need for closer follow-up. J Clin Gastroenterol 1999; 28 (02) 125-130
  • 28 Eckardt VF, Gockel I, Bernhard G. Pneumatic dilation for achalasia: late results of a prospective follow up investigation. Gut 2004; 53 (05) 629-633
  • 29 Di Nardo G, Rossi P, Oliva S. et al. Pneumatic balloon dilation in pediatric achalasia: efficacy and factors predicting outcome at a single tertiary pediatric gastroenterology center. Gastrointest Endosc 2012; 76 (05) 927-932
  • 30 Rohof WO, Salvador R, Annese V. et al. Outcomes of treatment for achalasia depend on manometric subtype. Gastroenterology 2013; 144 (04) 718-725 , quiz e13–e14
  • 31 Vanuytsel T, Lerut T, Coosemans W. et al. Conservative management of esophageal perforations during pneumatic dilation for idiopathic esophageal achalasia. Clin Gastroenterol Hepatol 2012; 10 (02) 142-149
  • 32 Litle VR. Laparoscopic Heller myotomy for achalasia: a review of the controversies. Ann Thorac Surg 2008; 85 (02) S743-S746
  • 33 Zaninotto G, Costantini M, Rizzetto C. et al. Four hundred laparoscopic myotomies for esophageal achalasia: a single centre experience. Ann Surg 2008; 248 (06) 986-993
  • 34 Luketich JD, Fernando HC, Christie NA. et al. Outcomes after minimally invasive esophagomyotomy. Ann Thorac Surg 2001; 72 (06) 1909-1912 , discussion 1912–1913
  • 35 Richards WO, Torquati A, Holzman MD. et al. Heller myotomy versus Heller myotomy with Dor fundoplication for achalasia: a prospective randomized double-blind clinical trial. Ann Surg 2004; 240 (03) 405-412 , discussion 412–415
  • 36 Vela MF, Richter JE, Khandwala F. et al. The long-term efficacy of pneumatic dilatation and Heller myotomy for the treatment of achalasia. Clin Gastroenterol Hepatol 2006; 4 (05) 580-587
  • 37 Yaghoobi M, Mayrand S, Martel M, Roshan-Afshar I, Bijarchi R, Barkun A. Laparoscopic Heller's myotomy versus pneumatic dilation in the treatment of idiopathic achalasia: a meta-analysis of randomized, controlled trials. Gastrointest Endosc 2013; 78 (03) 468-475
  • 38 Moonen A, Annese V, Belmans A. et al. Long-term results of the European achalasia trial: a multicentre randomised controlled trial comparing pneumatic dilation versus laparoscopic Heller myotomy. Gut 2016; 65 (05) 732-739
  • 39 Inoue H, Sato H, Ikeda H. et al. Per-oral endoscopic myotomy: a series of 500 patients. J Am Coll Surg 2015; 221 (02) 256-264
  • 40 Maydeo AP, Joshi NJ, Bhandari SP. Per oral endoscopic myotomy for a patient with achalasia cardia. J Assoc Physicians India 2012; 60: 66-68
  • 41 Akintoye E, Kumar N, Obaitan I, Alayo QA, Thompson CC. Peroral endoscopic myotomy: a meta-analysis. Endoscopy 2016; 48 (12) 1059-1068
  • 42 Werner YB, Hakanson B, Martinek J. et al. Endoscopic or surgical myotomy in patients with idiopathic achalasia. N Engl J Med 2019; 381 (23) 2219-2229
  • 43 Marano L, Pallabazzer G, Solito B. et al. Surgery or peroral esophageal myotomy for achalasia: a systematic review and meta-analysis. Medicine (Baltimore) 2016; 95 (10) e3001
  • 44 Schlottmann F, Luckett DJ, Fine J, Shaheen NJ, Patti MG. Laparoscopic Heller myotomy versus peroral endoscopic myotomy (POEM) for achalasia: a systematic review and meta-analysis. Ann Surg 2018; 267 (03) 451-460
  • 45 Ponds FA, Fockens P, Lei A. et al. Effect of peroral endoscopic myotomy vs pneumatic dilation on symptom severity and treatment outcomes among treatment-naive patients with achalasia: a randomized clinical trial. JAMA 2019; 322 (02) 134-144
  • 46 Stavropoulos SN, Desilets DJ, Fuchs K-H. et al. Per-oral endoscopic myotomy white paper summary. Surg Endosc 2014; 28 (07) 2005-2019
  • 47 Repici A, Fuccio L, Maselli R. et al. GERD after per-oral endoscopic myotomy as compared with Heller's myotomy with fundoplication: a systematic review with meta-analysis. Gastrointest Endosc 2018; 87 (04) 934-943.e18
  • 48 Bechara R, Inoue H, Shimamura Y, Reed D. Gastroesophageal reflux disease after peroral endoscopic myotomy: lest we forget what we already know. Dis Esophagus 2019; 32 (12) doz106
  • 49 Shiwaku H, Inoue H, Onimaru M. et al. Multicenter collaborative retrospective evaluation of peroral endoscopic myotomy for esophageal achalasia: analysis of data from more than 1300 patients at eight facilities in Japan. Surg Endosc 2020; 34 (01) 464-468
  • 50 Inoue H, Ueno A, Shimamura Y. et al. Peroral endoscopic myotomy and fundoplication: a novel NOTES procedure. Endoscopy 2019; 51 (02) 161-164
  • 51 Patil G, Dalal A, Maydeo A. Early outcomes of peroral endoscopic myotomy with fundoplication for achalasia cardia - is it here to stay?. Dig Endosc 2021; 33 (04) 561-568